Occidental Asset Management’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $277K | Sell |
9,853
-207
| -2% | -$5.51K | 0.03% | 225 |
|
|
2025
Q4 | $250K | Sell |
10,060
-1,172
| -10% | -$29.6K | 0.03% | 233 |
|
|
2025
Q3 | $286K | Buy |
+11,232
| New | +$277K | 0.04% | 209 |
|
|
2025
Q2 | – | Sell |
-9,360
| Closed | -$237K | – | 279 |
|
|
2025
Q1 | $237K | Sell |
9,360
-567
| -6% | -$14.8K | 0.04% | 221 |
|
|
2024
Q4 | $263K | Sell |
9,927
-3,847
| -28% | -$104K | 0.04% | 177 |
|
|
2024
Q3 | $399K | Buy |
13,774
+544
| +4% | +$15.9K | 0.06% | 154 |
|
|
2024
Q2 | $370K | Buy |
13,230
+2,627
| +25% | +$72.3K | 0.07% | 149 |
|
|
2024
Q1 | $294K | Sell |
10,603
-94
| -0.9% | -$2.61K | 0.06% | 160 |
|
|
2023
Q4 | $308K | Sell |
10,697
-642
| -6% | -$19.4K | 0.06% | 165 |
|
|
2023
Q3 | $376K | Sell |
11,339
-21
| -0.2% | -$743 | 0.09% | 149 |
|
|
2023
Q2 | $417K | Sell |
11,360
-28,153
| -71% | -$1.1M | 0.09% | 159 |
|
|
2023
Q1 | $1.61M | Buy |
39,513
+3,452
| +10% | +$149K | 0.4% | 77 |
|
|
2022
Q4 | $1.85M | Buy |
36,061
+2,371
| +7% | +$114K | 0.5% | 59 |
|
|
2022
Q3 | $1.47M | Buy |
33,690
+3,240
| +11% | +$157K | 0.44% | 67 |
|
|
2022
Q2 | $1.6M | Buy |
30,450
+2,618
| +9% | +$133K | 0.47% | 58 |
|
|
2022
Q1 | $1.44M | Buy |
27,832
+16,850
| +153% | +$874K | 0.37% | 75 |
|
|
2021
Q4 | $648K | Buy |
10,982
+592
| +6% | +$29.3K | 0.15% | 132 |
|
|
2021
Q3 | $447K | Buy |
10,390
+242
| +2% | +$10.7K | 0.12% | 146 |
|
|
2021
Q2 | $397K | Hold |
10,148
| – | – | 0.11% | 155 |
|
|
2021
Q1 | $368K | Buy |
10,148
+21
| +0.2% | +$746 | 0.11% | 151 |
|
|
2020
Q4 | $373K | Buy |
10,127
+1,407
| +16% | +$51.6K | 0.12% | 137 |
|
|
2020
Q3 | $304K | Hold |
8,720
| – | – | 0.13% | 118 |
|
|
2020
Q2 | $271K | Sell |
8,720
-632
| -7% | -$21.5K | 0.12% | 126 |
|
|
2020
Q1 | $290K | Sell |
9,352
-1,427
| -13% | -$48.6K | 0.15% | 116 |
|
|
2019
Q4 | $401K | Hold |
10,779
| – | – | 0.16% | 119 |
|
|
2019
Q3 | $367K | Hold |
10,779
| – | – | 0.15% | 120 |
|
|
2019
Q2 | $443K | Hold |
10,779
| – | – | 0.2% | 105 |
|
|
2019
Q1 | $434K | Hold |
10,779
| – | – | 0.21% | 102 |
|
|
2018
Q4 | $446K | Hold |
10,779
| – | – | 0.25% | 77 |
|
|
2018
Q3 | $451K | Hold |
10,779
| – | – | 0.23% | 89 |
|
|
2018
Q2 | $371K | Sell |
10,779
-743
| -6% | -$25.4K | 0.2% | 99 |
|
|
2018
Q1 | $388K | Hold |
11,522
| – | – | 0.21% | 92 |
|
|
2017
Q4 | $396K | Hold |
11,522
| – | – | 0.21% | 88 |
|
|
2017
Q3 | $390K | Hold |
11,522
| – | – | 0.22% | 80 |
|
|
2017
Q2 | $367K | Buy |
11,522
+376
| +3% | +$11.9K | 0.22% | 81 |
|
|
2017
Q1 | $362K | Hold |
11,146
| – | – | 0.24% | 75 |
|
|
2016
Q4 | $343K | Buy |
11,146
+738
| +7% | +$22.5K | 0.25% | 78 |
|
|
2016
Q3 | $334K | Hold |
10,408
| – | – | 0.27% | 70 |
|
|
2016
Q2 | $348K | Buy |
10,408
+2,059
| +25% | +$65.7K | 0.3% | 65 |
|
|
2016
Q1 | $235K | Hold |
8,349
| – | – | 0.28% | 64 |
|
|
2015
Q4 | $256K | Hold |
8,349
| – | – | 0.33% | 58 |
|
|
2015
Q3 | $234K | Hold |
8,349
| – | – | 0.33% | 58 |
|
|
2015
Q2 | $235K | Hold |
8,349
| – | – | 0.32% | 57 |
|
|
2015
Q1 | $254K | Hold |
8,349
| – | – | 0.32% | 55 |
|
|
2014
Q4 | $243K | Sell |
8,349
-8,569
| -51% | -$246K | 0.37% | 55 |
|
|
2014
Q3 | $461K | Sell |
16,918
-3,214
| -16% | -$90.2K | 0.75% | 32 |
|
|
2014
Q2 | $535K | Sell |
20,132
-762
| -4% | -$21.7K | 0.92% | 27 |
|
|
2014
Q1 | $572K | Buy |
+20,894
| New | +$623K | 1.02% | 22 |
|
Other funds holding PFE
VCM
VPM
Occidental Asset Management's PFE Position: Q1 2026 in Review
Occidental Asset Management reduced its Pfizer (PFE) stake by 2.1% in Q1 2026, selling an estimated $5.51K and leaving 9,853 shares worth $277K. The position accounts for 0.03% of the portfolio, ranked #225.
Occidental Asset Management first reported a position in PFE in Q1 2014 and has held it in 48 quarters since. The position peaked at $1.85M in Q4 2022. 2,938 funds tracked by Wall St. Rank hold PFE as of Q1 2026.
- Occidental Asset Management held 9,853 shares of Pfizer worth $277K as of Q1 2026.
- Occidental Asset Management sold 207 Pfizer shares in Q1 2026, an estimated $5.51K.
- Pfizer made up 0.03% of Occidental Asset Management's portfolio in Q1 2026, its #225 holding.
- Occidental Asset Management first reported a position in Pfizer in Q1 2014 and has held it in 48 quarters since.
- Occidental Asset Management's Pfizer position peaked at $1.85M in Q4 2022.
- 2,938 funds tracked by Wall St. Rank held Pfizer as of Q1 2026.
Based on Occidental Asset Management's 13F filing for Q1 2026, filed 16 Apr 2026.